Strategic pricing and market access
Shorter product development cycles and intense competition are constant threats to new pharmaceutical products or medical devices that often struggle to achieve their profit and volume objectives. Precise and comprehensive understanding of market needs and opportunities, of pricing options and therapeutic benefit, and in particular of approval and payment options is critical to overcome these barriers. Syreon Research Institute is optimally poised to provide these services. With extensive experience in the pharmaceutical industry, we work with companies to ensure that their products are optimally priced for rapid market uptake and are tightly aligned with patient and provider needs. The economic and pricing expertise of SRI helps companies move from developing products to creating value, and realizing the benefit of this transition.